Genetics of prion diseases

Current Opinion in Genetics and Development

Volumn 23, Issue 3, 2013, Pages 345-351

  Lloyd, Sarah E ^a   Mead, Simon ^a   Collinge, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MESSENGER RNA; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN SPONGIOSIS; CPNE8 GENE; CREUTZFELDT JAKOB DISEASE; GENE; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HECTD2 GENE; HIGH THROUGHPUT SCREENING; HSPA13 GENE; HUMAN; INHERITANCE; KURU; MTMR7 GENE; NEUROFIBRILLARY TANGLE; NONHUMAN; NPAS2 GENE; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PRNP GENE; QUANTITATIVE TRAIT LOCUS MAPPING; RARB GENE; RASA2 GENE; REVIEW; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STCH GENE; STMN2 GENE; TRANSGENICS; VARIANT CREUTZFELDT JAKOB DISEASE; ZBTB38 GENE;

ANIMALS; CARRIER PROTEINS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIONS;

ANIMALIA; BOVINAE;

EID: 84879881889     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.02.012     Document Type: Review

References (45)

1. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Ann Rev Neurosci 2001, 24:519-550.
2. Ironside J.W. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol 2012, 50:50-56.
3. Owen F., Poulter M., Lofthouse R., Collinge J., Crow T.J., Risby D., Baker H.F., Ridley R.M., Hsiao K., Prusiner S.B. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1989, 1:51-52.
4. Hsiao K., Baker H.F., Crow T.J., Poulter M., Owen F., Terwilliger J.D., Westaway D., Ott J., Prusiner S.B. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 1989, 338:342-345.
5. Palmer M.S., Dryden A.J., Hughes J.T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991, 352:340-342.
6. Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 2005, 76:906-919.
7. Mead S., Poulter M., Uphill J., Beck J., Whitfield J., Webb T.E., Campbell T., Adamson G., Deriziotis P., Tabrizi S.J., et al. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol 2009, 8:57-66.
8. Mead S., Uphill J., Beck J., Poulter M., Campbell T., Lowe J., Adamson G., Hummerich H., Klopp N., Ruckert I.M., et al. Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. Hum Mol Genet 2011, 21:1897-1906.
9. Sanchez-Juan P., Bishop M.T., Aulchenko Y.S., Brandel J.P., Rivadeneira F., Struchalin M., Lambert J.C., Amouyel P., Combarros O., Sainz J., et al. Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol Aging 2011, 33. 1487.e21-1487.e28.
10. Beck J.A., Poulter M., Campbell T.A., Adamson G., Uphill J.B., Guerreiro R., Jackson G.S., Stevens J.C., Manji H., Collinge J., Mead S. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 2010, 31:E1551-E1563.
11. Lee S.M., Ju Y.R., Choi B.-Y., Hyeon J.W., Park J.S., Kim C.K., Kim S.Y. Genotype patterns and characteristics of PRNP in the Korean population. Prion 2012, 6:375-382.
12. Nozaki I., Hamaguchi T., Sanjo N., Noguchi-Shinohara M., Sakai K., Nakamura Y., Sato T., Kitamoto T., Mizusawa H., Moriwaka F., et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain 2010, 133:3043-3057.
13. Beck J., Collinge J., Mead S. Prion protein gene M232R variation is probably an uncommon polymorphism rather than a pathogenic mutation. Brain 2012, 135:e209.
14. Jansen C., Parchi P., Capellari S., Strammiello R., Dopper E.G., van Swieten J.C., Kamphorst W., Rozemuller A.J. A second case of Gerstmann-Straussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. J Neuropathol Exp Neurol 2011, 70:698-702.
15. Gao C., Shi Q., Tian C., Chen C., Han J., Zhou W., Zhang B.Y., Jiang H.Y., Zhang J., Dong X.P. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS ONE 2011, 6:e24231.
16. Jansen C., Parchi P., Capellari S., Ibrahim-Verbaas C.A., Schuur M., Strammiello R., Corrado P., Bishop M.T., Van Gool W.A., Verbeek M.M., et al. Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. PLoS ONE 2012, 7:e36333.
17. Tartaglia M.C., Thai J.N., See T., Kuo A., Harbaugh R., Raudabaugh B., Cali I., Sattavat M., Sanchez H., DeArmond S.J., Geschwind M.D. Pathologic evidence that the T188R mutation in PRNP is associated with prion disease. J Neuropathol Exp Neurol 2010, 69:1220-1227.
18. Jayadev S., Nochlin D., Poorkaj P., Steinbart E.J., Mastrianni J.A., Montine T.J., Ghetti B., Schellenberg G.D., Bird T.D., Leverenz J.B. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann Neurol 2011, 69:712-720.
19. Imran M., Mahmood S., Hussain R., Abid N.B., Lone K.P. Frequency distribution of PRNP polymorphisms in the Pakistani population. Gene 2011, 492:186-194.
20. Kaski D.N., Pennington C., Beck J., Poulter M., Uphill J., Bishop M.T., Linehan J.M., O'Malley C., Wadsworth J.D., Joiner S., et al. Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors. Brain 2011, 134:1829-1838.
21. Lloyd S., Onwuazor O.N., Beck J., Mallinson G., Farrall M., Targonski P., Collinge J., Fisher E. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 2001, 98:6279-6283.
22. Lloyd S., Uphill J.B., Targonski P.V., Fisher E., Collinge J. Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics 2002, 4:77-81.
23. Stephenson D.A., Chiotti K., Ebeling C., Groth D., DeArmond S.J., Prusiner S.B., Carlson G.A. Quantitative trait loci affecting prion incubation time in mice. Genomics 2000, 69:47-53.
24. Manolakou K., Beaton J., McConnell I., Farquar C., Manson J., Hastie N.D., Bruce M., Jackson I.J. Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A 2001, 98:7402-7407.
25. Moreno C.R., Lantier F., Lantier I., Sarradin P., Elsen J.M. Detection of new quantitative trait loci for susceptibility to transmissible spongiform encephalopathies in mice. Genetics 2003, 165:2085-2091.
26. Iyegbe C.O., Abiola O.O., Towlson C., Powell J.F., Whatley S.A. Evidence for varied aetiologies regulating the transmission of prion disease: implications for understanding the heritable basis of prion incubation times. PLoS ONE 2010, 5:e14186.
27. Hitzemann B., Dains K., Kanes S., Hitzemann R. Further-studies on the relationship between dopamine cell-density and haloperidol-induced catalepsy. J Pharm Exp Ther 1994, 271:969-976.
28. Valdar W., Solberg L.C., Gauguier D., Burnett S., Klenerman P., Cookson O., Taylor M.S., Rawlins J.N.P., Mott R., Flint J. Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genet 2006, 38:879-887.
29. Welsh C.E., Miller D.R., Manly K.F., Wang J., McMillan L., Morahan G., Mott R., Iraqi F.A., Threadgill D.W., de Villena F.P. Status and access to the Collaborative Cross population. Mamm Genome 2012, 23:706-712.
30. Lloyd S.E., Maytham E.G., Pota H., Grizenkova J., Molou E., Uphill J., Hummerich H., Whitfield J., Alpers M.P., Mead S., Collinge J. HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet 2009, 5:e1000383.
31. Grizenkova J., Akhtar S., Collinge J., Lloyd S.E. The retinoic acid receptor Beta (rarb) region of mmu14 is associated with prion disease incubation time in mouse. PLoS ONE 2010, 5:e15019.
32. 2+-dependent phospholipid-binding proteins. Cell Mol Life Sci 2002, 59:1467-1477.
33. Hwang D., Lee I.Y., Yoo H., Gehlenborg N., Cho J.H., Petritis B., Baxter D., Pitstick R., Young R., Spicer D., et al. A systems approach to prion disease. Mol Syst Biol 2009, 5:252.
34. Zampieri M., Legname G., Segre D., Altafini C. A system-level approach for deciphering the transcriptional response to prion infection. Bioinformatics 2011, 27:3407-3414.
35. Grizenkova J., Akhtar S., Hummerich H., Tomlinson A., Asante E.A., Wenborn A., Fizet J., Poulter M., Wiseman F.K., Fisher E.M., et al. Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice. Proc Natl Acad Sci U S A 2012, 109:13722-13727.
36. Otterson G.A., Flynn G.C., Kratzke R.A., Coxon A., Johnston P.G., Kaye F.J. Stch encodes the atpase core of a microsomal stress70 protein. EMBO J 1994, 13:1216-1225.
37. Yamagata N., Furuno K., Sonoda M., Sugimura H., Yamamoto K. Stomach cancer-derived del223V-226L mutation of the STCH gene causes loss of sensitization to TRAIL-mediated apoptosis. Biochem Biophys Res Commun 2008, 376:499-503.
38. Collinge J., Clarke A. A general model of prion strains and their pathogenicity. Science 2007, 318:930-936.
39. Brundin P., Melki R., Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010, 11:301-307.
40. Lawson V.A., Klemm H.M., Welton J.M., Masters C.L., Crouch P., Cappai R., Ciccotosto G.D. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease. J Neuropathol Exp Neurol 2011, 70:1036-1045.
41. Asuni A.A., Hilton K., Siskova Z., Lunnon K., Reynolds R., Perry V.H., O'Connor V. Alpha-synuclein deficiency in the C57Bl/6JOlaHsd strain does not modify disease progression in the me7-model of prion disease. Neuroscience 2010, 165:662-674.
42. Mougenot A.L., Bencsik A., Nicot S., Vulin J., Morignat E., Verchere J., Betemps D., Lakhdar L., Legastelois S., Baron T.G. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated alpha-synuclein. J Neuropathol Exp Neurol 2011, 70:377-385.
43. Klohn P., Stoltze L., Flechsig E., Enari M., Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A 2003, 100:11666-11671.
44. White M.D., Farmer M., Mirabile I., Brandner S., Collinge J., Mallucci G.R. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A 2008, 105:10238-10243.
45. Lloyd S.E., Maytham E.G., Grizenkova J., Hummerich H., Collinge J. A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse. Neurogenetics 2010, 11:185-191.